News & Press releases

Update on major activities on this page. Follow further updates on our Linkedin page

nov 2021

Series B Fundraise Closes

River Stone Biotech Inc. Announces $6.8M Series B Financing to Advance Lead Pipeline Projects. Goal: To Treat Opiate Use Disorder and Opiate Overdose

may 2022

Strategic Update

River Stone Biotech Inc. participates in DCAT 2022  conference and announces its ambition in becoming a global provider of substance abuse APIs.